Search
Powered By HealthLine
Special Offers
Health Tools
 Quiz: How Addicted Are You?
 Guide to Living Smoke Free
 Smoking Health Risks
 Video: Targeting Lung Cancer
 Stop Smoking Basics
Featured Conditions
 Asthma
 Diabetes
 Stop Smoking
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Nicotine Patch Plus Lozenge Best for Quitting Smoking


Related Encyclopedia
 border=
Acne
Angina Pectoris
Angiogram
Angioplasty
More...

Related Healthscout Videos
 border=
How Can an Adult ADHD Patient Get More Organized?
Bipolar Kids: A New Battlefront
Attacking Addiction: Cure in a Cocktail?
Body Dysmorphic Disorder- A Serious Disease
More...

Related Drug Information
 border=
Adderal XR
Concerta
Effexor XR
Paxil
More...

Related News Articles
 border=
Recession May Be Changing Americans' Attitudes Toward Work
Brain's Pleasure Chemical May Explain Men's Higher Alcoholism Rate
Iraq War Vet, Daytime TV Star Turns Scars Into Inspiration
Mom's Suicide May Raise Child's Odds for Later Suicide Attempt
More...


Page:  << Prev | 1 | 2 | 3 | Next >>

This research was funded by the U.S. National Institutes of Health. Medication was provided free by drug maker GlaxoSmithKline. Several of the study authors reported financial ties to different pharmaceutical companies.

For this study, 1,504 adults who had smoked at least half a pack a day for the past six months and wanted to quit were randomly assigned to a placebo or one of five different quit-smoking interventions: nicotine lozenge, nicotine patch, bupropion (Wellbutrin, an antidepressant), nicotine patch plus nicotine lozenge, and bupropion plus nicotine lozenge. All groups received six individual counseling sessions with a case manager.

The nicotine patch, which has been available for more than two decades, is currently the most widely used pharmacotherapy to help people quit smoking.

Text Continues Below



However, only the combination of the nicotine patch and the lozenge performed significantly better than placebo six months after the person smoked their last cigarette, the team found.

People taking the patch-lozenge combination were also more likely to have sworn off cigarettes after one week and were more likely to have attained one full day without smoking, the researchers said.

The 40 percent (at six months) success rate reported here will decline as time goes on, Whiteson noted. He added, however, that in the smoking cessation arena, "even the 30 percent range is very good."

Another expert said the study raised some key concerns. "The question is, how many of them had to continue on the lozenge in order to stay off cigarettes? I always tell people not to do the lozenge alone because it mimics the very thing that smoking does, which gives you a spike. Then, when you reach a trough, you pick up a lozenge -- or cigarette," said Dr. Len Horovitz, a pulmonary specialist with Lenox Hill Hospital in New York City. "Once they stopped everything, could they do without the spikes and troughs [of the lozenge], which mimics physiologically everything the cigarette is doing? Smoking is a two-pronged problem. There's nicotine dependence and a behavioral aspect to it."

Page:  << Prev | 1 | 2 | 3 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 11/2/2009

Related Links
 border=
From Healthscout's partner site on asthma, MyAsthmaCentral.com
VIDEO: Lung stents help asthmatics to breathe easier
TREATMENT: Medication and lifestyle changes provide asthma relief
DRUGS: Common drugs used to treat asthma





SOURCES: Megan E. Piper, Ph.D., assistant professor, Center for Tobacco Research and Intervention, University of Wisconsin, Madison; Jonathan H. Whiteson, M.D., co-director, Joan and Joel Smilow Cardiopulmonary Rehabilitation and Prevention Center, NYU Langone Medical Center, New York City; Elliot Wineburg, M.D., assistant clinical professor of psychiatry, Mount Sinai School of Medicine, New York City; Len Horovitz, pulmonary specialist, Lenox Hill Hospital, New York City; November 2009 Archives of General Psychiatry


HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2010. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire